SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PDL who wrote (1751)2/18/1999 2:33:00 PM
From: BMcV  Read Replies (2) of 10280
 
Seems like a very aggressive forecast. This is from the ML report: "We continue to expect profitability by mid-2001 and rapid EPS growth thereafter". Now we're talking over $5? This changes everything if it's realistic. Stocks can trade on earnings 2 years out. Hope they're not hyping us. Here's the rest of the article that just came in:

02/18 13:36 *SEPRACOR <SEPR.O> AGREES WITH ANALYST ASSUMPTIONS BEHIND
2001 EPS VIEW 0F $5.69

By Ransdell Pierson

NEW YORK, Feb 18 (Reuters) - Sepracor Inc. <SEPR.O> shares jumped to a new high Thursday after the company, which is now losing money, endorsed a bullish earnings forecast for the years 2001-2003.

Chief Financial Officer David Southwell told Reuters that he believed an earnings per share forecast by Morgan Stanley Dean Witter analyst Douglas Lind of $13.48 for the year 2003 was "conservative."

Southwell said he agreed with the "underlying assumptions" behind Lind's forecast of $5.69 per share for the year 2001 and $10.38 for 2002.

Shares of the Massachussetts-based biotech company were up 9-7/16 at 128 on the Nasdaq. The previous intraday high for the company, which specializes in making safer versions of existing drugs, was 121-3/8.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext